Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) Stock Competitors & Peer Comparison
See OACCW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Shell Companies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for OACCW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OACCW | $0.57 | -37.52% | 158.8M | 2.06 | $0.27 | N/A |
| CCIV | $24.25 | +5.90% | 44.4B | N/A | N/A | N/A |
| PSACU | $17.08 | +0.35% | 12B | -108.79 | -$0.16 | N/A |
| RTPY | $9.91 | -0.30% | 11.6B | N/A | N/A | N/A |
| LVRAW | $0.04 | +0.00% | 11.5B | N/A | N/A | N/A |
| CMLFU | $13.00 | -4.55% | 10.3B | -1444.44 | -$0.01 | N/A |
| PSAC | $13.78 | -0.36% | 9.7B | N/A | N/A | N/A |
| GRSVU | $11.39 | +3.36% | 6.8B | N/A | N/A | N/A |
| APSG | $7.39 | -25.88% | 6.3B | 36.95 | $0.20 | N/A |
| RTP | $10.03 | -4.48% | 6.3B | N/A | N/A | N/A |
Stock Comparison
Lucid Group, Inc. (NYSE: CCIV)
OACCW vs CCIV Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CCIV has a market cap of 44.4B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CCIV trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CCIV's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to CCIV's ROE of -13.92%. Regarding short-term risk, OACCW is less volatile compared to CCIV. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CCIV's competition here
Property Solutions Acquisition Corp. (NASDAQ: PSACU)
OACCW vs PSACU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, PSACU has a market cap of 12B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while PSACU trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas PSACU's P/E ratio is -108.79. In terms of profitability, OACCW's ROE is +0.03%, compared to PSACU's ROE of +118.85%. Regarding short-term risk, OACCW is less volatile compared to PSACU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check PSACU's competition here
Reinvent Technology Partners Y (NASDAQ: RTPY)
OACCW vs RTPY Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, RTPY has a market cap of 11.6B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while RTPY trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas RTPY's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to RTPY's ROE of -0.48%. Regarding short-term risk, OACCW is less volatile compared to RTPY. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check RTPY's competition here
Levere Holdings Corp. (NASDAQ: LVRAW)
OACCW vs LVRAW Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, LVRAW has a market cap of 11.5B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while LVRAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas LVRAW's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to LVRAW's ROE of N/A. Regarding short-term risk, OACCW is less volatile compared to LVRAW. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check LVRAW's competition here
CM Life Sciences, Inc. (NASDAQ: CMLFU)
OACCW vs CMLFU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CMLFU has a market cap of 10.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CMLFU trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CMLFU's P/E ratio is -1444.44. In terms of profitability, OACCW's ROE is +0.03%, compared to CMLFU's ROE of -0.39%. Regarding short-term risk, OACCW is less volatile compared to CMLFU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CMLFU's competition here
Property Solutions Acquisition Corp. (NASDAQ: PSAC)
OACCW vs PSAC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, PSAC has a market cap of 9.7B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while PSAC trades at $13.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas PSAC's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to PSAC's ROE of +118.85%. Regarding short-term risk, OACCW is less volatile compared to PSAC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check PSAC's competition here
Gores Holdings V, Inc. (NASDAQ: GRSVU)
OACCW vs GRSVU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, GRSVU has a market cap of 6.8B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while GRSVU trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas GRSVU's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to GRSVU's ROE of +0.00%. Regarding short-term risk, OACCW is similarly volatile compared to GRSVU. This indicates similar risk in terms of short-term price fluctuations for OACCW.Check GRSVU's competition here
Apollo Strategic Growth Capital (NYSE: APSG)
OACCW vs APSG Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, APSG has a market cap of 6.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while APSG trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas APSG's P/E ratio is 36.95. In terms of profitability, OACCW's ROE is +0.03%, compared to APSG's ROE of +0.03%. Regarding short-term risk, OACCW is less volatile compared to APSG. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check APSG's competition here
Reinvent Technology Partners (NYSE: RTP)
OACCW vs RTP Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, RTP has a market cap of 6.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while RTP trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas RTP's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to RTP's ROE of -0.58%. Regarding short-term risk, OACCW is less volatile compared to RTP. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check RTP's competition here
Dragoneer Growth Opportunities Corp. (NYSE: DGNR)
OACCW vs DGNR Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, DGNR has a market cap of 5.8B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while DGNR trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas DGNR's P/E ratio is -308.67. In terms of profitability, OACCW's ROE is +0.03%, compared to DGNR's ROE of +0.04%. Regarding short-term risk, OACCW is less volatile compared to DGNR. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check DGNR's competition here
VectoIQ Acquisition Corp. II (NASDAQ: VTIQ)
OACCW vs VTIQ Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, VTIQ has a market cap of 5.6B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while VTIQ trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas VTIQ's P/E ratio is 91.50. In terms of profitability, OACCW's ROE is +0.03%, compared to VTIQ's ROE of +472.81%. Regarding short-term risk, OACCW is less volatile compared to VTIQ. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check VTIQ's competition here
VectoIQ Acquisition Corp. II (NASDAQ: VTIQU)
OACCW vs VTIQU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, VTIQU has a market cap of 5.6B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while VTIQU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas VTIQU's P/E ratio is 100.60. In terms of profitability, OACCW's ROE is +0.03%, compared to VTIQU's ROE of +472.81%. Regarding short-term risk, OACCW is similarly volatile compared to VTIQU. This indicates similar risk in terms of short-term price fluctuations for OACCW.Check VTIQU's competition here
Vector Acquisition Corporation (NASDAQ: VACQ)
OACCW vs VACQ Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, VACQ has a market cap of 5.5B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while VACQ trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas VACQ's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to VACQ's ROE of -0.08%. Regarding short-term risk, OACCW is less volatile compared to VACQ. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check VACQ's competition here
SVF Investment Corp. 3 (NASDAQ: SVFC)
OACCW vs SVFC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, SVFC has a market cap of 5.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while SVFC trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas SVFC's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to SVFC's ROE of +0.05%. Regarding short-term risk, OACCW is less volatile compared to SVFC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check SVFC's competition here
VG Acquisition Corp. (NYSE: VGAC)
OACCW vs VGAC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, VGAC has a market cap of 5B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while VGAC trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas VGAC's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to VGAC's ROE of -1.21%. Regarding short-term risk, OACCW is less volatile compared to VGAC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check VGAC's competition here
CM Life Sciences III Inc. (NASDAQ: CMLT)
OACCW vs CMLT Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CMLT has a market cap of 4.2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CMLT trades at $8.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CMLT's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to CMLT's ROE of N/A. Regarding short-term risk, OACCW is less volatile compared to CMLT. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CMLT's competition here
Gores Holdings VI, Inc. (NASDAQ: GHVI)
OACCW vs GHVI Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, GHVI has a market cap of 4.2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while GHVI trades at $14.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas GHVI's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to GHVI's ROE of -1.28%. Regarding short-term risk, OACCW is less volatile compared to GHVI. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check GHVI's competition here
Nextdoor Holdings, Inc. (NASDAQ: KVSB)
OACCW vs KVSB Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, KVSB has a market cap of 4.2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while KVSB trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas KVSB's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to KVSB's ROE of -0.07%. Regarding short-term risk, OACCW is less volatile compared to KVSB. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check KVSB's competition here
FTAC Olympus Acquisition Corp. (NASDAQ: FTOCU)
OACCW vs FTOCU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, FTOCU has a market cap of 4.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while FTOCU trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas FTOCU's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to FTOCU's ROE of +0.07%. Regarding short-term risk, OACCW is less volatile compared to FTOCU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check FTOCU's competition here
Tuscan Holdings Corp. (NASDAQ: THCBU)
OACCW vs THCBU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, THCBU has a market cap of 3.9B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while THCBU trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas THCBU's P/E ratio is -101.87. In terms of profitability, OACCW's ROE is +0.03%, compared to THCBU's ROE of +0.01%. Regarding short-term risk, OACCW is less volatile compared to THCBU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check THCBU's competition here
Climate Change Crisis Real Impact I Acquisition Corporation (NYSE: CLII)
OACCW vs CLII Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CLII has a market cap of 3.8B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CLII trades at $14.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CLII's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to CLII's ROE of -0.31%. Regarding short-term risk, OACCW is less volatile compared to CLII. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CLII's competition here
GreenVision Acquisition Corp. (NASDAQ: GRNV)
OACCW vs GRNV Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, GRNV has a market cap of 3.8B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while GRNV trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas GRNV's P/E ratio is -59.68. In terms of profitability, OACCW's ROE is +0.03%, compared to GRNV's ROE of +0.04%. Regarding short-term risk, OACCW is less volatile compared to GRNV. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check GRNV's competition here
Forest Road Acquisition Corp. (NYSE: FRX)
OACCW vs FRX Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, FRX has a market cap of 3.7B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while FRX trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas FRX's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to FRX's ROE of +0.39%. Regarding short-term risk, OACCW is less volatile compared to FRX. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check FRX's competition here
Holicity Inc. (NASDAQ: HOLUU)
OACCW vs HOLUU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, HOLUU has a market cap of 3.7B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while HOLUU trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas HOLUU's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to HOLUU's ROE of -0.13%. Regarding short-term risk, OACCW is less volatile compared to HOLUU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check HOLUU's competition here
Silver Spike Acquisition Corp. (NASDAQ: SSPK)
OACCW vs SSPK Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, SSPK has a market cap of 3.4B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while SSPK trades at $18.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas SSPK's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to SSPK's ROE of +0.04%. Regarding short-term risk, OACCW is less volatile compared to SSPK. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check SSPK's competition here
Falcon Capital Acquisition Corp. (NASDAQ: FCACU)
OACCW vs FCACU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, FCACU has a market cap of 3.4B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while FCACU trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas FCACU's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to FCACU's ROE of -0.00%. Regarding short-term risk, OACCW is less volatile compared to FCACU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check FCACU's competition here
CF Acquisition Corp. VI (NASDAQ: CFVI)
OACCW vs CFVI Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CFVI has a market cap of 3.4B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CFVI trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CFVI's P/E ratio is -18.55. In terms of profitability, OACCW's ROE is +0.03%, compared to CFVI's ROE of -0.47%. Regarding short-term risk, OACCW is less volatile compared to CFVI. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CFVI's competition here
Holicity Inc. (NASDAQ: HOL)
OACCW vs HOL Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, HOL has a market cap of 3.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while HOL trades at $12.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas HOL's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to HOL's ROE of -0.13%. Regarding short-term risk, OACCW is less volatile compared to HOL. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check HOL's competition here
Tuscan Holdings Corp. (NASDAQ: THCB)
OACCW vs THCB Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, THCB has a market cap of 3.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while THCB trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas THCB's P/E ratio is -81.30. In terms of profitability, OACCW's ROE is +0.03%, compared to THCB's ROE of +0.01%. Regarding short-term risk, OACCW is less volatile compared to THCB. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check THCB's competition here
Sustainable Opportunities Acquisition Corp. (NYSE: SOAC)
OACCW vs SOAC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, SOAC has a market cap of 2.8B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while SOAC trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas SOAC's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to SOAC's ROE of +0.53%. Regarding short-term risk, OACCW is less volatile compared to SOAC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check SOAC's competition here
Decarbonization Plus Acquisition Corporation (NASDAQ: DCRBU)
OACCW vs DCRBU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, DCRBU has a market cap of 2.8B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while DCRBU trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas DCRBU's P/E ratio is -16.00. In terms of profitability, OACCW's ROE is +0.03%, compared to DCRBU's ROE of -0.84%. Regarding short-term risk, OACCW is less volatile compared to DCRBU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check DCRBU's competition here
Ivanhoe Capital Acquisition Corp. (NYSE: IVAN)
OACCW vs IVAN Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, IVAN has a market cap of 2.7B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while IVAN trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas IVAN's P/E ratio is -698.18. In terms of profitability, OACCW's ROE is +0.03%, compared to IVAN's ROE of -0.33%. Regarding short-term risk, OACCW is less volatile compared to IVAN. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check IVAN's competition here
Good Works Acquisition Corp. (NASDAQ: GWAC)
OACCW vs GWAC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, GWAC has a market cap of 2.6B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while GWAC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas GWAC's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to GWAC's ROE of -0.59%. Regarding short-term risk, OACCW is less volatile compared to GWAC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check GWAC's competition here
Landcadia Holdings III, Inc (NASDAQ: LCYAU)
OACCW vs LCYAU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, LCYAU has a market cap of 2.6B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while LCYAU trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas LCYAU's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to LCYAU's ROE of +0.04%. Regarding short-term risk, OACCW is similarly volatile compared to LCYAU. This indicates similar risk in terms of short-term price fluctuations for OACCW.Check LCYAU's competition here
Fifth Wall Acquisition Corp. I (NASDAQ: FWAA)
OACCW vs FWAA Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, FWAA has a market cap of 2.4B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while FWAA trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas FWAA's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to FWAA's ROE of -0.09%. Regarding short-term risk, OACCW is less volatile compared to FWAA. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check FWAA's competition here
GS Acquisition Holdings Corp II (NYSE: GSAH)
OACCW vs GSAH Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, GSAH has a market cap of 2.4B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while GSAH trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas GSAH's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to GSAH's ROE of +0.45%. Regarding short-term risk, OACCW is less volatile compared to GSAH. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check GSAH's competition here
Landcadia Holdings III, Inc (NASDAQ: LCY)
OACCW vs LCY Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, LCY has a market cap of 2.4B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while LCY trades at $12.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas LCY's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to LCY's ROE of +0.04%. Regarding short-term risk, OACCW is less volatile compared to LCY. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check LCY's competition here
Foresight Acquisition Corp. (NASDAQ: FORE)
OACCW vs FORE Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, FORE has a market cap of 2.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while FORE trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas FORE's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to FORE's ROE of +3.90%. Regarding short-term risk, OACCW is less volatile compared to FORE. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check FORE's competition here
Revolution Acceleration Acquisition Corp (NASDAQ: RAAC)
OACCW vs RAAC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, RAAC has a market cap of 2.2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while RAAC trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas RAAC's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to RAAC's ROE of +0.00%. Regarding short-term risk, OACCW is less volatile compared to RAAC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check RAAC's competition here
Supernova Partners Acquisition Company, Inc. (NYSE: SPNV)
OACCW vs SPNV Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, SPNV has a market cap of 2.2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while SPNV trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas SPNV's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to SPNV's ROE of -0.99%. Regarding short-term risk, OACCW is less volatile compared to SPNV. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check SPNV's competition here
Social Capital Suvretta Holdings Corp. III (NASDAQ: DNAC)
OACCW vs DNAC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, DNAC has a market cap of 2.2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while DNAC trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas DNAC's P/E ratio is -37.72. In terms of profitability, OACCW's ROE is +0.03%, compared to DNAC's ROE of -0.36%. Regarding short-term risk, OACCW is less volatile compared to DNAC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check DNAC's competition here
Fortress Value Acquisition Corp. II (NYSE: FAII)
OACCW vs FAII Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, FAII has a market cap of 2.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while FAII trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas FAII's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to FAII's ROE of -0.32%. Regarding short-term risk, OACCW is less volatile compared to FAII. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check FAII's competition here
dMY Technology Group, Inc. III (NYSE: DMYI)
OACCW vs DMYI Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, DMYI has a market cap of 2.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while DMYI trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas DMYI's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to DMYI's ROE of -0.16%. Regarding short-term risk, OACCW is less volatile compared to DMYI. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check DMYI's competition here
Live Oak Acquisition Corp. II (NYSE: LOKB)
OACCW vs LOKB Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, LOKB has a market cap of 2.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while LOKB trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas LOKB's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to LOKB's ROE of -0.62%. Regarding short-term risk, OACCW is less volatile compared to LOKB. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check LOKB's competition here
Star Peak Corp II (NYSE: STPC)
OACCW vs STPC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, STPC has a market cap of 2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while STPC trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas STPC's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to STPC's ROE of -0.29%. Regarding short-term risk, OACCW is less volatile compared to STPC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check STPC's competition here
Mudrick Capital Acquisition Corporation II (NASDAQ: MUDS)
OACCW vs MUDS Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, MUDS has a market cap of 2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while MUDS trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas MUDS's P/E ratio is 3.39. In terms of profitability, OACCW's ROE is +0.03%, compared to MUDS's ROE of -0.01%. Regarding short-term risk, OACCW is less volatile compared to MUDS. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check MUDS's competition here
Mudrick Capital Acquisition Corporation II (NASDAQ: MUDSU)
OACCW vs MUDSU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, MUDSU has a market cap of 2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while MUDSU trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas MUDSU's P/E ratio is -1125.56. In terms of profitability, OACCW's ROE is +0.03%, compared to MUDSU's ROE of -0.01%. Regarding short-term risk, OACCW is similarly volatile compared to MUDSU. This indicates similar risk in terms of short-term price fluctuations for OACCW.Check MUDSU's competition here
Tiga Acquisition Corp. (NYSE: TINV)
OACCW vs TINV Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, TINV has a market cap of 2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while TINV trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas TINV's P/E ratio is 30.61. In terms of profitability, OACCW's ROE is +0.03%, compared to TINV's ROE of +3.57%. Regarding short-term risk, OACCW is less volatile compared to TINV. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check TINV's competition here
Apex Treasury Corporation (NASDAQ: APXTU)
OACCW vs APXTU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, APXTU has a market cap of 1.9B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while APXTU trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas APXTU's P/E ratio is 75.70. In terms of profitability, OACCW's ROE is +0.03%, compared to APXTU's ROE of +0.06%. Regarding short-term risk, OACCW is similarly volatile compared to APXTU. This indicates similar risk in terms of short-term price fluctuations for OACCW.Check APXTU's competition here
Apex Treasury Corporation Class A (NASDAQ: APXT)
OACCW vs APXT Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, APXT has a market cap of 1.9B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while APXT trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas APXT's P/E ratio is 74.74. In terms of profitability, OACCW's ROE is +0.03%, compared to APXT's ROE of +0.06%. Regarding short-term risk, OACCW is similarly volatile compared to APXT. This indicates similar risk in terms of short-term price fluctuations for OACCW.Check APXT's competition here
Apex Treasury Corporation (NASDAQ: APXTW)
OACCW vs APXTW Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, APXTW has a market cap of 1.9B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while APXTW trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas APXTW's P/E ratio is 2.06. In terms of profitability, OACCW's ROE is +0.03%, compared to APXTW's ROE of +0.06%. Regarding short-term risk, OACCW is less volatile compared to APXTW. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check APXTW's competition here
Digital World Acquisition Corp. (NASDAQ: DWAC)
OACCW vs DWAC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, DWAC has a market cap of 1.9B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while DWAC trades at $49.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas DWAC's P/E ratio is -73.46. In terms of profitability, OACCW's ROE is +0.03%, compared to DWAC's ROE of -0.84%. Regarding short-term risk, OACCW is less volatile compared to DWAC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check DWAC's competition here
Digital World Acquisition Corp. (NASDAQ: DWACU)
OACCW vs DWACU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, DWACU has a market cap of 1.9B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while DWACU trades at $61.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas DWACU's P/E ratio is -451.10. In terms of profitability, OACCW's ROE is +0.03%, compared to DWACU's ROE of -0.84%. Regarding short-term risk, OACCW is less volatile compared to DWACU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check DWACU's competition here
Athena Technology Acquisition Corp. (NYSE: ATHN)
OACCW vs ATHN Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, ATHN has a market cap of 1.8B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while ATHN trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas ATHN's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to ATHN's ROE of +2.24%. Regarding short-term risk, OACCW is less volatile compared to ATHN. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check ATHN's competition here
Gores Metropoulos II, Inc. (NASDAQ: GMII)
OACCW vs GMII Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, GMII has a market cap of 1.8B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while GMII trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas GMII's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to GMII's ROE of +1.03%. Regarding short-term risk, OACCW is less volatile compared to GMII. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check GMII's competition here
Motive Capital Corp. (NYSE: MOTV)
OACCW vs MOTV Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, MOTV has a market cap of 1.7B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while MOTV trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas MOTV's P/E ratio is 55.86. In terms of profitability, OACCW's ROE is +0.03%, compared to MOTV's ROE of -0.15%. Regarding short-term risk, OACCW is less volatile compared to MOTV. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check MOTV's competition here
CBRE Acquisition Holdings, Inc. (NYSE: CBAH)
OACCW vs CBAH Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CBAH has a market cap of 1.7B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CBAH trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CBAH's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to CBAH's ROE of +0.04%. Regarding short-term risk, OACCW is less volatile compared to CBAH. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CBAH's competition here
GX Acquisition Corp. (NASDAQ: GXGXU)
OACCW vs GXGXU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, GXGXU has a market cap of 1.7B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while GXGXU trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas GXGXU's P/E ratio is -23.73. In terms of profitability, OACCW's ROE is +0.03%, compared to GXGXU's ROE of -0.03%. Regarding short-term risk, OACCW is less volatile compared to GXGXU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check GXGXU's competition here
One (NYSE: AONE)
OACCW vs AONE Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, AONE has a market cap of 1.7B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while AONE trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas AONE's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to AONE's ROE of -17.11%. Regarding short-term risk, OACCW is less volatile compared to AONE. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check AONE's competition here
Tortoise Acquisition Corp. II (NYSE: SNPR)
OACCW vs SNPR Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, SNPR has a market cap of 1.6B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while SNPR trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas SNPR's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to SNPR's ROE of +0.00%. Regarding short-term risk, OACCW is less volatile compared to SNPR. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check SNPR's competition here
Jaws Spitfire Acquisition Corporation (NYSE: SPFR)
OACCW vs SPFR Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, SPFR has a market cap of 1.6B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while SPFR trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas SPFR's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to SPFR's ROE of -4.57%. Regarding short-term risk, OACCW is less volatile compared to SPFR. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check SPFR's competition here
D8 Holdings Corp. (NYSE: DEH)
OACCW vs DEH Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, DEH has a market cap of 1.6B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while DEH trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas DEH's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to DEH's ROE of -3.33%. Regarding short-term risk, OACCW is less volatile compared to DEH. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check DEH's competition here
Rotor Acquisition Corp. (NYSE: ROT)
OACCW vs ROT Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, ROT has a market cap of 1.6B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while ROT trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas ROT's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to ROT's ROE of -0.45%. Regarding short-term risk, OACCW is less volatile compared to ROT. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check ROT's competition here
NextGen Acquisition Corporation (NASDAQ: NGAC)
OACCW vs NGAC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, NGAC has a market cap of 1.5B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while NGAC trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas NGAC's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to NGAC's ROE of -0.80%. Regarding short-term risk, OACCW is less volatile compared to NGAC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check NGAC's competition here
Celularity Inc. (NASDAQ: GXGX)
OACCW vs GXGX Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, GXGX has a market cap of 1.5B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while GXGX trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas GXGX's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to GXGX's ROE of +2.05%. Regarding short-term risk, OACCW is less volatile compared to GXGX. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check GXGX's competition here
Hudson Executive Investment Corp. (NASDAQ: HECCU)
OACCW vs HECCU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, HECCU has a market cap of 1.4B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while HECCU trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas HECCU's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to HECCU's ROE of -0.10%. Regarding short-term risk, OACCW is less volatile compared to HECCU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check HECCU's competition here
Altimar Acquisition Corp. II (NYSE: ATMR)
OACCW vs ATMR Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, ATMR has a market cap of 1.4B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while ATMR trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas ATMR's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to ATMR's ROE of +0.44%. Regarding short-term risk, OACCW is less volatile compared to ATMR. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check ATMR's competition here
Osprey Technology Acquisition Corp. (NYSE: SFTW)
OACCW vs SFTW Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, SFTW has a market cap of 1.4B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while SFTW trades at $11.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas SFTW's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to SFTW's ROE of -0.56%. Regarding short-term risk, OACCW is less volatile compared to SFTW. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check SFTW's competition here
890 5th Avenue Partners, Inc. (NASDAQ: ENFA)
OACCW vs ENFA Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, ENFA has a market cap of 1.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while ENFA trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas ENFA's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to ENFA's ROE of -1.15%. Regarding short-term risk, OACCW is less volatile compared to ENFA. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check ENFA's competition here
Environmental Impact Acquisition Corp. (NASDAQ: ENVI)
OACCW vs ENVI Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, ENVI has a market cap of 1.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while ENVI trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas ENVI's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to ENVI's ROE of +0.00%. Regarding short-term risk, OACCW is less volatile compared to ENVI. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check ENVI's competition here
ArcLight Clean Transition Corp. II (NASDAQ: ACTD)
OACCW vs ACTD Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, ACTD has a market cap of 1.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while ACTD trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas ACTD's P/E ratio is -25.50. In terms of profitability, OACCW's ROE is +0.03%, compared to ACTD's ROE of -0.00%. Regarding short-term risk, OACCW is less volatile compared to ACTD. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check ACTD's competition here
Vickers Vantage Corp. I (NASDAQ: VCKA)
OACCW vs VCKA Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, VCKA has a market cap of 1.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while VCKA trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas VCKA's P/E ratio is 100.11. In terms of profitability, OACCW's ROE is +0.03%, compared to VCKA's ROE of +1.87%. Regarding short-term risk, OACCW is less volatile compared to VCKA. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check VCKA's competition here
Churchill Capital Corp XI Warrants (NASDAQ: CCXIW)
OACCW vs CCXIW Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CCXIW has a market cap of 1.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CCXIW trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CCXIW's P/E ratio is -1.41. In terms of profitability, OACCW's ROE is +0.03%, compared to CCXIW's ROE of N/A. Regarding short-term risk, OACCW is less volatile compared to CCXIW. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CCXIW's competition here
Thimble Point Acquisition Corp. (NASDAQ: THMA)
OACCW vs THMA Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, THMA has a market cap of 1.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while THMA trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas THMA's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to THMA's ROE of +0.00%. Regarding short-term risk, OACCW is less volatile compared to THMA. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check THMA's competition here
L&F Acquisition Corp. (NYSE: LNFA)
OACCW vs LNFA Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, LNFA has a market cap of 1.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while LNFA trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas LNFA's P/E ratio is 21.06. In terms of profitability, OACCW's ROE is +0.03%, compared to LNFA's ROE of +0.09%. Regarding short-term risk, OACCW is less volatile compared to LNFA. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check LNFA's competition here
Fintech Acquisition Corp. IV (NASDAQ: FTIVU)
OACCW vs FTIVU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, FTIVU has a market cap of 1.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while FTIVU trades at $14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas FTIVU's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to FTIVU's ROE of -0.51%. Regarding short-term risk, OACCW is less volatile compared to FTIVU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check FTIVU's competition here
ACON S2 Acquisition Corp. (NASDAQ: STWO)
OACCW vs STWO Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, STWO has a market cap of 1.3B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while STWO trades at $8.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas STWO's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to STWO's ROE of +4.68%. Regarding short-term risk, OACCW is less volatile compared to STWO. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check STWO's competition here
Haymaker Acquisition Corp. III (NASDAQ: HYACU)
OACCW vs HYACU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, HYACU has a market cap of 1.2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while HYACU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas HYACU's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to HYACU's ROE of -0.11%. Regarding short-term risk, OACCW is less volatile compared to HYACU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check HYACU's competition here
Fintech Acquisition Corp. IV (NASDAQ: FTIV)
OACCW vs FTIV Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, FTIV has a market cap of 1.2B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while FTIV trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas FTIV's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to FTIV's ROE of -0.51%. Regarding short-term risk, OACCW is less volatile compared to FTIV. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check FTIV's competition here
Alpha Healthcare Acquisition Corp. (NASDAQ: AHAC)
OACCW vs AHAC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, AHAC has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while AHAC trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas AHAC's P/E ratio is -72.11. In terms of profitability, OACCW's ROE is +0.03%, compared to AHAC's ROE of -5.42%. Regarding short-term risk, OACCW is less volatile compared to AHAC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check AHAC's competition here
Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC)
OACCW vs AMHC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, AMHC has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while AMHC trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas AMHC's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to AMHC's ROE of +0.00%. Regarding short-term risk, OACCW is less volatile compared to AMHC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check AMHC's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERA)
OACCW vs HERA Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, HERA has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while HERA trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas HERA's P/E ratio is 46.32. In terms of profitability, OACCW's ROE is +0.03%, compared to HERA's ROE of +0.01%. Regarding short-term risk, OACCW is less volatile compared to HERA. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check HERA's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERAW)
OACCW vs HERAW Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, HERAW has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while HERAW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas HERAW's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to HERAW's ROE of +0.01%. Regarding short-term risk, OACCW is less volatile compared to HERAW. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check HERAW's competition here
FG New America Acquisition Corp. (NYSE: FGNA)
OACCW vs FGNA Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, FGNA has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while FGNA trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas FGNA's P/E ratio is -4.35. In terms of profitability, OACCW's ROE is +0.03%, compared to FGNA's ROE of +0.46%. Regarding short-term risk, OACCW is less volatile compared to FGNA. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check FGNA's competition here
Social Capital Suvretta Holdings Corp. I (NASDAQ: DNAA)
OACCW vs DNAA Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, DNAA has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while DNAA trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas DNAA's P/E ratio is -54.53. In terms of profitability, OACCW's ROE is +0.03%, compared to DNAA's ROE of +0.00%. Regarding short-term risk, OACCW is less volatile compared to DNAA. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check DNAA's competition here
Therapeutics Acquisition Corp. (NASDAQ: RACA)
OACCW vs RACA Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, RACA has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while RACA trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas RACA's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to RACA's ROE of +0.00%. Regarding short-term risk, OACCW is less volatile compared to RACA. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check RACA's competition here
Trebia Acquisition Corp. (NYSE: TREB)
OACCW vs TREB Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, TREB has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while TREB trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas TREB's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to TREB's ROE of -12.26%. Regarding short-term risk, OACCW is less volatile compared to TREB. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check TREB's competition here
TPG Pace Tech Opportunities Corp. (NYSE: PACE)
OACCW vs PACE Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, PACE has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while PACE trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas PACE's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to PACE's ROE of -1.52%. Regarding short-term risk, OACCW is less volatile compared to PACE. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check PACE's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERAU)
OACCW vs HERAU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, HERAU has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while HERAU trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas HERAU's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to HERAU's ROE of +0.01%. Regarding short-term risk, OACCW is less volatile compared to HERAU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check HERAU's competition here
LifeSci Acquisition II Corp. (NASDAQ: LSAQ)
OACCW vs LSAQ Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, LSAQ has a market cap of 1.1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while LSAQ trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas LSAQ's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to LSAQ's ROE of N/A. Regarding short-term risk, OACCW is less volatile compared to LSAQ. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check LSAQ's competition here
Stable Road Acquisition Corp. (NASDAQ: SRAC)
OACCW vs SRAC Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, SRAC has a market cap of 1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while SRAC trades at $10.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas SRAC's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to SRAC's ROE of -0.90%. Regarding short-term risk, OACCW is less volatile compared to SRAC. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check SRAC's competition here
FTAC Parnassus Acquisition Corp. (NASDAQ: FTPAW)
OACCW vs FTPAW Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, FTPAW has a market cap of 1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while FTPAW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas FTPAW's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to FTPAW's ROE of -0.00%. Regarding short-term risk, OACCW is similarly volatile compared to FTPAW. This indicates similar risk in terms of short-term price fluctuations for OACCW.Check FTPAW's competition here
Sandbridge Acquisition Corporation (NYSE: SBG)
OACCW vs SBG Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, SBG has a market cap of 1B. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while SBG trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas SBG's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to SBG's ROE of -0.51%. Regarding short-term risk, OACCW is less volatile compared to SBG. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check SBG's competition here
Churchill Capital Corp VII (NYSE: CVII-WT)
OACCW vs CVII-WT Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CVII-WT has a market cap of 977.9M. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CVII-WT trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CVII-WT's P/E ratio is N/A. In terms of profitability, OACCW's ROE is +0.03%, compared to CVII-WT's ROE of +0.02%. Regarding short-term risk, OACCW is less volatile compared to CVII-WT. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CVII-WT's competition here
Churchill Capital Corp VII (NYSE: CVII-UN)
OACCW vs CVII-UN Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CVII-UN has a market cap of 958.8M. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CVII-UN trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CVII-UN's P/E ratio is 64.65. In terms of profitability, OACCW's ROE is +0.03%, compared to CVII-UN's ROE of +0.02%. Regarding short-term risk, OACCW is less volatile compared to CVII-UN. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CVII-UN's competition here
Bleichroeder Acquisition Corp. II (NASDAQ: BBCQW)
OACCW vs BBCQW Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, BBCQW has a market cap of 954.5M. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while BBCQW trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas BBCQW's P/E ratio is -25.90. In terms of profitability, OACCW's ROE is +0.03%, compared to BBCQW's ROE of N/A. Regarding short-term risk, OACCW is less volatile compared to BBCQW. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check BBCQW's competition here
B. Riley Principal 150 Merger Corp. (NASDAQ: BRPM)
OACCW vs BRPM Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, BRPM has a market cap of 944M. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while BRPM trades at $13.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas BRPM's P/E ratio is -72.74. In terms of profitability, OACCW's ROE is +0.03%, compared to BRPM's ROE of +4.56%. Regarding short-term risk, OACCW is less volatile compared to BRPM. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check BRPM's competition here
Crescent Acquisition Corp. (NASDAQ: CRSAU)
OACCW vs CRSAU Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CRSAU has a market cap of 937.8M. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CRSAU trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CRSAU's P/E ratio is -27.21. In terms of profitability, OACCW's ROE is +0.03%, compared to CRSAU's ROE of -0.34%. Regarding short-term risk, OACCW is less volatile compared to CRSAU. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CRSAU's competition here
Churchill Capital Corp VII (NYSE: CVII)
OACCW vs CVII Comparison November 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCW) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCW stands at 158.8M. In comparison, CVII has a market cap of 914.7M. Regarding current trading prices, OACCW is priced at $0.57 on the NASDAQ, while CVII trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCW currently has a P/E ratio of 2.06, whereas CVII's P/E ratio is 999.00. In terms of profitability, OACCW's ROE is +0.03%, compared to CVII's ROE of +0.02%. Regarding short-term risk, OACCW is less volatile compared to CVII. This indicates lower risk in terms of short-term price fluctuations for OACCW.Check CVII's competition here